Skip to main content

Table 1 General data of the study population

From: T2 mapping of molecular subtypes of WHO grade II/III gliomas

 

IDH-mut (n = 18)

IDH-wt (n = 12)

p-value*

age, yr. (mean, range)

41,32 ± 12,3 [28–74]

55,69 ± 16,39 [34–81]

0,0105

A2

38,13 ± 11,53 [28–57]

64,22 ± 18,25 [41–81]

AA3

42,55 ± 12,81 [29–74]

51,42 ± 14,73 [34–74]

sex (no.)

n = 18

n = 12

< 0,0001

female

9 (50%)

1 (8,33%)

male

9 (50%)

11 (91,67%)

tumor grade

n = 18

n = 12

A2

5 (27,78%)

4 (33,33%)

AA3

13 (72,22%)

8 (66,67%)

tumor localization

n = 18

n = 12

< 0,0001**

fronto-parietal

frontal (38,89%)

parietal (16,67%)

frontoparietal (11,1%)

frontal (16,67%)

parietal (16,67%)

other

fronto-parieto-temporal (16,67%)

temporal (11,1%)

parieto-temporal (5,56%)

thalamic (25%)

temporal (16,67%)

frontotemporal (8,33%)

corpus callosum (8,33%)

5 single lesions (8,33%)

 
  1. *All p-values relate to the difference between IDH-mut and IDH-wt independently of the tumor grade. **This p-value concerns to fronto-parietal or not fronto-parietal localization in IDH-mut and IDH-wt tumors